UK Cancer Researcher Fights Disease Using Counterintuitive Approach

UK Cancer Researcher Fights Disease Using Counterintuitive Approach
A researcher at Wellcome Trust/Cancer Research UK Gurdon Institute developed a counterintuitive approach to fighting cancer that led to the development of Lynparza (olaparib) as a prescribed medication for certain types of BRCA-mutated advanced ovarian cancer. The therapeutic approach is now being considered for other types of cancer that might also derive from BRCA mutations,

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *